{"nct_id":"NCT06436742","title":"A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2024-09-24","start_date_type":"ACTUAL","primary_completion_date":"2025-11-25","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11-25","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ARGX"]}